Protara Therapeutics
Stock Forecast, Prediction & Price Target
Protara Therapeutics Financial Estimates
Protara Therapeutics Revenue Estimates
Protara Therapeutics EBITDA Estimates
Protara Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $24.86M Low: $24.86M High: $24.86M avg. 0% | Avg: $35.37M Low: $35.37M High: $35.37M avg. 42.25% | Avg: $45.89M Low: $45.89M High: $45.89M avg. 29.74% | Avg: $82.48M Low: $82.48M High: $82.48M avg. 79.71% |
Net Income
% change YoY
| $-47.13M N/A | $-64.81M -37.50% | $-40.42M 37.63% | Avg: $-60.32M Low: $-55.41M High: $-19.14M avg. -49.24% | Avg: $-66.87M Low: $-49.97M High: $-17.79M avg. -10.86% | Avg: $-24.36M Low: $-24.36M High: $-24.36M avg. 63.57% | Avg: $-14.05M Low: $-14.05M High: $-14.05M avg. 42.32% |
EBITDA
% change YoY
| $-47.25M N/A | $-8.02M 83.01% | $-43.27M -439.01% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$4.2 N/A | -$5.76 -37.14% | -$3.57 38.02% | Avg: -$3.08 Low: -$4.89 High: -$1.69 avg. 13.79% | Avg: -$3.33 Low: -$4.41 High: -$1.57 avg. -8.31% | Avg: -$2.15 Low: -$2.15 High: -$2.15 avg. 35.49% | Avg: -$1.24 Low: -$1.24 High: -$1.24 avg. 42.32% |
Operating Expenses
% change YoY
| $47.48M N/A | $37.54M -20.93% | $43.61M 16.16% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Protara Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 11.44% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -55.41M, average is -60.32M and high is -19.14M.
What is Protara Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 37.93% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $24.86M, average is $24.86M and high is $24.86M.
What is Protara Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 20.82% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$4.89, average is -$3.08 and high is $-1.69.